Meyer Fedida’s practice focuses on U.S. federal tax matters, with a particular emphasis on complex M&A transactions and joint ventures, private equity fund formation, and cross-border tax planning.

Meyer joined the firm in 2003 and became partner in 2015. He was previously resident in the London office.

Notable Experiences

Corporate M&A

  • T-Mobile in its pending up to $1.35 billion acquisition of Ka’ena and its subsidiaries and brands, Mint Mobile, Ultra Mobile, and Plum.

  • Cascade Investment in its $4.7 billion acquisition of Signature Aviation (as part of a consortium with Blackstone and Global Infrastructure Partners).

  • National Amusements (the Redstone family holding company) with respect to its investments in CBS and Viacom, including the $30.5 billion merger of CBS and Viacom.

  • General Motors in the sale of its Opel/Vauxhall subsidiaries and European financial operations to PSA Group.

  • Google in numerous transactions, including its acquisition of Raxium.

  • GlaxoSmithKline in its $1.9 billion acquisition of Sierra Oncology.

  • Kindred Healthcare in its $4.1 billion sale to a consortium comprising TPG, Welsh Carson Anderson & Stowe, and Humana, and in its $1.8 billion acquisition of Gentiva Health Services.

  • LATAM Airlines in its $1.9 billion strategic partnership with Delta.

  • BNP Paribas in its novel transaction in relation to Deutsche Bank’s global prime brokerage and electronic equities businesses, and in its acquisition of Deutsche Bank’s Delta One hedge derivatives book.

  • Donatella Versace, GiVi Holding, and Jonathan Akeroyd in the $2.13 billion sale of Versace to Michael Kors.

  • Thales in its €4.8 billion tender offer for Gemalto and its related divestment of its General Purpose Hardware Security Module business to Entrust.

  • Lafarge in its €40 billion merger of equals with Holcim to create LafargeHolcim.

  • Takeda Pharmaceutical Co. in its $5.2 billion acquisition of ARIAD Pharmaceuticals.

  • BHP Billiton in the demerger of South 32 (initial capitalization of $9.1 billion).

  • Alstom in its €6.2 billion acquisition of Bombardier Transportation.

  • Cohu in its acquisition of Xcerra.

  • Safran in the sale of its identity and security activities (Safran I&S) for €2.425 billion.

  • Amundi in its €3.5 billion acquisition of Pioneer Investments from UniCredit.

  • Merck & Co. in its joint venture with Sanofi Pasteur for the exploitation of hexavalent vaccine Vaxelis.

  • Evraz Group S.A. in its $4 billion acquisition of IPSCO Inc. and simultaneous divestiture of certain of the purchased assets.

  • MEDNAX in its sales of American Anesthesiology to North American Partners in Anesthesia and MedData to Frazier Healthcare Partners.

  • Saint-Gobain in its $928 million acquisition of Kaycan.

  • Sysco in its acquisition of Greco and Sons and of The Coastal Companies.

See More

Private Equity M&A

  • TPG (and its portfolio companies) in connection with various transactions including:

    • Astound Broadband in its sale to Stonepeak Infrastructure Partners for $8.1 billion.
    • TPG in its $1.3 billion sale of United Family Healthcare.
    • RCN Telecom Services in its $2.36 billion acquisition of Wave Broadband;
    • Cushman & Wakefield in its IPO and pre-IPO restructuring and previously DTZ in the $2 billion acquisition of Cushman & Wakefield, and TPG, PAG, and OTPP in the $1.2 billion acquisition of DTZ from UGL and of Cassidy Turley;
    • Envision Pharmaceutical Holdings (a national, full-service pharmacy benefit management company) in its $2 billion sale to Rite Aid (and TPG in its prior acquisition of Envision Pharmaceutical Holdings); and
    • TPG in its investments in Uber.
  • Warburg Pincus in several transactions.

  • Carlyle Global Partners in several transactions.

  • Sequoia and Paradigm in their $1.15 billion minority investment in Citadel Securities.

  • Groupe Marc de Lacharrière (the family holding company of Marc Ladreit de Lacharrière) in its investment resulting in a 5% stake in private equity firm Warburg Pincus.

See More

Private Equity Fund Formation

  • TPG in a wide range of fund matters, including the formation and operation of its private equity, social impact, and other specialty funds, including TPG Partners V, VI, VII, and VIII; TPG Healthcare Partners; TPG Growth II, III, IV, and V; The Rise Fund I and II; and TPG Asia V, VI, and VII.

  • The Blackstone Group and Blackstone Alternative Asset Management in connection with various investment funds, including Blackstone Life Sciences Yield and Blackstone Life Sciences Fund V.

  • The Carlyle Group in connection with various investment funds.

  • Regular advisor to various large family offices and private foundations in their private equity investments.

See More

Selected Activities

Member, Tax Section Executive Committee, New York State Bar Association; Co-Chair Committee on Partnerships

Member, New York Private Investment Funds Tax Forum


Tax Highlights of the CARES Act Stimulus,” Cleary Gottlieb Alert Memo, March 28, 2020

Principal author, “Report on the Branch Loss Recapture Rules of Section 91,” New York State Bar Association Tax Section, August 29, 2019

Proposed IRS Regulations Would Largely Eliminate “Section 956 Deemed Dividends” for U.S. Multinationals and Expand the Range of Credit Support From Non-U.S. Subsidiaries That They Can Provide to Lenders,” Cleary Gottlieb Alert Memo, November 1, 2018

Applying the Repatriation Tax to Individuals,” Tax Notes, March 5, 2017.

Tax Cuts and Jobs Act: Our Insights

TCJA Technical Glitches, Minority Investments in Foreign Corps.,” Tax Notes, November 20, 2017.

Principal author, “Report on the Partnership Audit Rules of the Bipartisan Budget Act of 2015,” New York State Bar Association Tax Section, May 2016.